• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用血管紧张素II的选择性激动剂类似物——对氨基苯丙氨酸6血管紧张素II鉴别两种血管紧张素II受体亚型

Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.

作者信息

Speth R C, Kim K H

机构信息

Department of Veterinary and Comparative Anatomy, Washington State University, Pullman 99164.

出版信息

Biochem Biophys Res Commun. 1990 Jun 29;169(3):997-1006. doi: 10.1016/0006-291x(90)91993-3.

DOI:10.1016/0006-291x(90)91993-3
PMID:2194459
Abstract

Angiotensin II receptor binding sites in rat liver and PC12 cells differ in their affinities for a nonpeptidic antagonist, DuP 753, and p-aminophenylalanine6 angiotensin II. In liver, which primarily contains the sulfhydryl reducing agent-inhibited type of angiotensin II receptor, which we refer to as the AII alpha subtype, DuP 753 displays an IC50 of 55 nM, while p-aminophenylalanine6 angiotensin II displays an IC50 of 8-9 microM. In PC12 cells, which primarily contain the angiotensin II receptor type whose binding affinity is enhanced by sulfhydryl reducing agents (AII beta), DuP 753 displays an IC50 in excess of 100 microM, while p-aminophenylalanine6 angiotensin II displays an IC50 of 12 nM. p-Aminophenylalanine6 angiotensin II binding affinity in liver is decreased in the presence of guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S) suggesting that this analogue is an agonist.

摘要

大鼠肝脏和PC12细胞中的血管紧张素II受体结合位点对非肽类拮抗剂DuP 753和对氨基苯丙氨酸6血管紧张素II的亲和力不同。在主要含有巯基还原剂抑制型血管紧张素II受体(我们称之为AIIα亚型)的肝脏中,DuP 753的IC50为55 nM,而对氨基苯丙氨酸6血管紧张素II的IC50为8 - 9 μM。在主要含有巯基还原剂增强其结合亲和力的血管紧张素II受体类型(AIIβ)的PC12细胞中,DuP 753的IC50超过100 μM,而对氨基苯丙氨酸6血管紧张素II的IC50为12 nM。在鸟苷5'-O-(3-硫代三磷酸)(GTPγS)存在的情况下,肝脏中对氨基苯丙氨酸6血管紧张素II的结合亲和力降低,表明该类似物是一种激动剂。

相似文献

1
Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-aminophenylalanine6 angiotensin II.利用血管紧张素II的选择性激动剂类似物——对氨基苯丙氨酸6血管紧张素II鉴别两种血管紧张素II受体亚型
Biochem Biophys Res Commun. 1990 Jun 29;169(3):997-1006. doi: 10.1016/0006-291x(90)91993-3.
2
Angiotensin II receptor subtypes in the rat brain.大鼠脑中的血管紧张素II受体亚型。
Eur J Pharmacol. 1990 Sep 21;186(2-3):339-42. doi: 10.1016/0014-2999(90)90457-h.
3
Binding of [3H]angiotensin II and [3H]DuP 753 (Losartan) to rat liver homogenates reveals multiple sites. Relationship to AT1a- and AT1b-type angiotensin receptors and novel nonangiotensin binding sites.
Peptides. 1993 Jul-Aug;14(4):829-37. doi: 10.1016/0196-9781(93)90121-v.
4
Modulation of angiotensin II binding affinity by allosteric interaction of polyvinyl sulfate with an intracellular domain of the DuP-753-sensitive angiotensin II receptor of bovine adrenal glomerulosa.聚硫酸乙烯酯与牛肾上腺球状带中对DuP-753敏感的血管紧张素II受体细胞内结构域的变构相互作用对血管紧张素II结合亲和力的调节
Mol Pharmacol. 1992 Apr;41(4):809-15.
5
In vitro pharmacology of L-158,809, a new highly potent and selective angiotensin II receptor antagonist.
J Pharmacol Exp Ther. 1992 Jul;262(1):133-8.
6
The hepatic angiotensin II receptor. II. Effect of guanine nucleotides and interaction with cyclic AMP production.肝血管紧张素II受体。II. 鸟嘌呤核苷酸的作用及与环磷酸腺苷生成的相互作用
J Biol Chem. 1982 May 10;257(9):4959-65.
7
Angiotensin-II receptor subtypes in fetal tissue of the rat: autoradiography, guanine nucleotide sensitivity, and association with phosphoinositide hydrolysis.
Endocrinology. 1991 Aug;129(2):1075-82. doi: 10.1210/endo-129-2-1075.
8
Two distinct angiotensin II receptor binding sites in rat adrenal revealed by new selective nonpeptide ligands.新型选择性非肽类配体揭示大鼠肾上腺中两个不同的血管紧张素II受体结合位点。
Mol Pharmacol. 1990 Mar;37(3):347-51.
9
Rabbit renal epithelial angiotensin II receptors.兔肾上皮细胞血管紧张素II受体
Am J Physiol. 1994 Nov;267(5 Pt 2):F776-82. doi: 10.1152/ajprenal.1994.267.5.F776.
10
[3H]DUP 753, a highly potent and specific radioligand for the angiotensin II-1 receptor subtype.[3H]DUP 753,一种针对血管紧张素II-1受体亚型的高效且特异性的放射性配体。
Biochem Biophys Res Commun. 1990 Nov 15;172(3):1195-202. doi: 10.1016/0006-291x(90)91575-d.

引用本文的文献

1
Comparative evaluation of biased agonists Sarcosine , d-Alanine -Angiotensin (Ang) II (SD Ang II) and Sarcosine , Isoleucine -Ang II (SI Ang II) and their radioiodinated congeners binding to rat liver membrane AT receptors.沙丙氨酸、d-丙氨酸-血管紧张素(Ang)II(SD Ang II)和沙丙氨酸、异亮氨酸-血管紧张素 II(SI Ang II)及其放射性碘标记同系物与大鼠肝细胞膜 AT 受体的结合比较评价。
Pharmacol Res Perspect. 2023 Feb;11(1):e01053. doi: 10.1002/prp2.1053.
2
CGP42112: the full AT2 receptor agonist and its role in the renin-angiotensin-aldosterone system: no longer misunderstood.CGP42112:全 AT2 受体激动剂及其在肾素-血管紧张素-醛固酮系统中的作用:不再被误解。
Clin Sci (Lond). 2022 Nov 11;136(21):1513-1533. doi: 10.1042/CS20220261.
3
The Angiotensin AT Receptor: From a Binding Site to a Novel Therapeutic Target.
血管紧张素 AT 受体:从结合位点到新的治疗靶点。
Pharmacol Rev. 2022 Oct;74(4):1051-1135. doi: 10.1124/pharmrev.120.000281.
4
Structural perspectives on the mechanism of signal activation, ligand selectivity and allosteric modulation in angiotensin receptors: IUPHAR Review 34.血管紧张素受体信号激活、配体选择性和变构调节机制的结构观点:国际药理学联合会评论 34。
Br J Pharmacol. 2022 Sep;179(18):4461-4472. doi: 10.1111/bph.15840. Epub 2022 Apr 23.
5
Alterations in Gene Expression of Renin-Angiotensin System Components and Related Proteins in Colorectal Cancer.肾素-血管紧张素系统成分和相关蛋白在结直肠癌中的基因表达改变。
J Renin Angiotensin Aldosterone Syst. 2021 Jul 5;2021:9987115. doi: 10.1155/2021/9987115. eCollection 2021.
6
High affinity rigidified AT receptor ligands with indane scaffolds.具有茚满支架的高亲和力刚性化AT受体配体。
Medchemcomm. 2019 Nov 18;10(12):2146-2160. doi: 10.1039/c9md00402e. eCollection 2019 Dec 1.
7
International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].国际基础与临床药理学联合会。XCIX. 血管紧张素受体:病理生理血管紧张素能刺激的解读器[校正后]
Pharmacol Rev. 2015 Oct;67(4):754-819. doi: 10.1124/pr.114.010454.
8
Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors.针对血管紧张素 II 1型和2型受体的分子的合理药物设计与合成。
Molecules. 2015 Mar 2;20(3):3868-97. doi: 10.3390/molecules20033868.
9
Structural determinants for binding to angiotensin converting enzyme 2 (ACE2) and angiotensin receptors 1 and 2.与血管紧张素转换酶 2(ACE2)和血管紧张素受体 1 和 2 结合的结构决定因素。
Front Pharmacol. 2015 Jan 30;6:5. doi: 10.3389/fphar.2015.00005. eCollection 2015.
10
Saralasin and Sarile Are AT2 Receptor Agonists.沙拉新和萨立来是血管紧张素Ⅱ2型受体激动剂。
ACS Med Chem Lett. 2014 Aug 18;5(10):1129-32. doi: 10.1021/ml500278g. eCollection 2014 Oct 9.